News
The biggest stories of the day delivered to your inbox.
The biggest stories of the day delivered to your inbox.
This study found that using GLP-1 RAs and SGLT2is for type 2 diabetes treatment offers potential neuroprotections against Alzheimer disease and related dementias. HealthDay News — Both glucagon ...
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them. (HealthDay News) — Both glucagon-like peptide-1 receptor agonists ...
The man. The myth. The legend.” Balhan’s father died last year after struggling with dementia. During one episode late in his life, he became so agitated that he tried to exit a moving car.
But using gadgets such as smartphones and computers in later life could lower the risk of dementia, according to a study. There have been growing concerns about the widespread use of digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results